What is the address of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE?

The registered office of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE is located at Rue de la Lesse,Han 6, 5580 Rochefort.

Is GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE still active?

Yes. According to the CBE (29 September 2026) GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE is active, legal situation “Normale toestand”, started on 16 January 2009.

Is GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE registered on Peppol?

No, GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE is currently not registered on the Peppol network.

What is the enterprise number of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE?

The enterprise number of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE is BE0809181225.

When was GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE founded?

GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE was founded on 16 January 2009.

Who are the directors of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE?

According to the 2025 annual accounts, the directors of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE are: Martine Grégoire, Gaetan Rosoux.

Is GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2009; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE make in 2025?

GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE posted a profit after taxes of € 36,556 in financial year 2025.

What is the revenue of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE?

In its most recent annual accounts (2025), GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE reported revenue of € 145,310.

GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE (Private Limited)

Dossier GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE, printed on 29 September 2026 from databakkes.be/en/0809181225/gaetan-rosoux-kinesitherapie-osteopathie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE from Rochefort, company number BE0809181225, closed financial year 2025 with a result of € 36,556 after tax. For that financial year GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE recorded revenue of € 145,310 and equity of € 169,021. Compared with financial year 2024, the result moved from € 35,250 to € 36,556. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 169,021

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 36,556

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 54,436

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 22,800 paid out

62 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 34,606

▲ € 33,064 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 366

▼ 52% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,000

▼ 33% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 118,078 Revenue 2022: € 118,078 First fiscal year in the series	€ 137,360 Revenue 2023: € 137,360 ▲ 16% vs 2022 (€ 118,078) Favourable step	€ 151,582 Revenue 2024: € 151,582 ▲ 10% vs 2023 (€ 137,360) Favourable step	€ 145,310 Revenue 2025: € 145,310 ▼ 4% vs 2024 (€ 151,582) Unfavourable step	▼ 4%
Gross margin	€ 25,068 Gross margin 2022: € 25,068 First fiscal year in the series	€ 52,418 Gross margin 2023: € 52,418 ▲ 109% vs 2022 (€ 25,068) Favourable step	€ 55,971 Gross margin 2024: € 55,971 ▲ 7% vs 2023 (€ 52,418) Favourable step	€ 63,638 Gross margin 2025: € 63,638 ▲ 14% vs 2024 (€ 55,971) Favourable step	▲ 14%
Profit after taxes	€ 9,112 Profit after taxes 2022: € 9,112 First fiscal year in the series	€ 25,695 Profit after taxes 2023: € 25,695 ▲ 182% vs 2022 (€ 9,112) Favourable step	€ 35,250 Profit after taxes 2024: € 35,250 ▲ 37% vs 2023 (€ 25,695) Favourable step	€ 36,556 Profit after taxes 2025: € 36,556 ▲ 4% vs 2024 (€ 35,250) Favourable step	▲ 4%
Equity	€ 120,120 Equity 2022: € 120,120 First fiscal year in the series	€ 130,815 Equity 2023: € 130,815 ▲ 9% vs 2022 (€ 120,120) Favourable step	€ 155,265 Equity 2024: € 155,265 ▲ 19% vs 2023 (€ 130,815) Favourable step	€ 169,021 Equity 2025: € 169,021 ▲ 9% vs 2024 (€ 155,265) Favourable step	▲ 9%
Total debts	€ 3,452 Total debts 2022: € 3,452 First fiscal year in the series	€ 3,926 Total debts 2023: € 3,926 ▲ 14% vs 2022 (€ 3,452) Unfavourable step	€ 12,831 Total debts 2024: € 12,831 ▲ 227% vs 2023 (€ 3,926) Unfavourable step	€ 8,166 Total debts 2025: € 8,166 ▼ 36% vs 2024 (€ 12,831) Favourable step	▼ 36%
Cash	€ 31,228 Cash 2022: € 31,228 First fiscal year in the series	€ 52,051 Cash 2023: € 52,051 ▲ 67% vs 2022 (€ 31,228) Favourable step	€ 65,106 Cash 2024: € 65,106 ▲ 25% vs 2023 (€ 52,051) Favourable step	€ 54,436 Cash 2025: € 54,436 ▼ 16% vs 2024 (€ 65,106) Unfavourable step	▼ 16%
Retained profit	€ 84,220 Retained profit 2022: € 84,220 First fiscal year in the series	€ 94,915 Retained profit 2023: € 94,915 ▲ 13% vs 2022 (€ 84,220) Favourable step	€ 119,365 Retained profit 2024: € 119,365 ▲ 26% vs 2023 (€ 94,915) Favourable step	€ 133,121 Retained profit 2025: € 133,121 ▲ 12% vs 2024 (€ 119,365) Favourable step	▲ 12%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 15,000 Dividend 2023: € 15,000 ▲ € 14,200 vs 2022 (€ 800) Unchanged	€ 10,800 Dividend 2024: € 10,800 ▼ 28% vs 2023 (€ 15,000) Unchanged	€ 22,800 Dividend 2025: € 22,800 ▲ 111% vs 2024 (€ 10,800) Unchanged	▲ 111%
Balance sheet total	€ 124,073 Balance sheet total 2022: € 124,073 First fiscal year in the series	€ 135,241 Balance sheet total 2023: € 135,241 ▲ 9% vs 2022 (€ 124,073) Unchanged	€ 168,596 Balance sheet total 2024: € 168,596 ▲ 25% vs 2023 (€ 135,241) Unchanged	€ 177,688 Balance sheet total 2025: € 177,688 ▲ 5% vs 2024 (€ 168,596) Unchanged	▲ 5%

Key figures of GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE?

What happened at GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 36,556 (▲ 4% vs 2024). Source: NBB ↗
Jan 16, 2009 New establishment in Dinant. KBO
Jan 16, 2009 New establishment in Rochefort. KBO
Jan 16, 2009 Start of the company according to the CBE. KBO

In short

From € 9,112 profit in 2022 to € 36,556 profit in 2025.

Paid € 53,264 in corporate taxes since 2022.

Best year ever: 2025, with € 36,556 profit.

Paid out € 49,400 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE? We notify you, reason included.

Follow GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Martine Grégoire Gaetan Rosoux

GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE

Behind GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE are Martine Grégoire and Gaetan Rosoux.

See the full network in the app

Directors

According to the 2025 annual accounts

Martine Grégoire

Manager

Gaetan Rosoux

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Lesse,Han 6

5580 Rochefort

2.261.901.824

Pont-d'Amour 50

5500 Dinant

Active since 16 January 2009

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0809.181.225
VAT number: BE 0809.181.225
Registered office: Rue de la Lesse,Han 6, 5580 Rochefort
Names & denominations: GAETAN ROSOUX KINESITHERAPIE OSTEOPATHIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗